Clinical Trial Update: Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated repeated super-selective intraarterial infusion of bevacizumab for newly diagnosed glioblastoma multiforme; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma Multiforme, Brain Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-30